CISD2 and metabolic dysfunction-associated steatohepatitis: Specifically, Cisd2 haploinsufficiency, namely one copy of Cisd2 in the liver, is insufficient and this accelerates the pathogenesis of NAFLD and exacerbates progression toward NASH.